| For: | O’Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer. World J Gastroenterol 2018; 24(39): 4436-4447 [PMID: 30357021 DOI: 10.3748/wjg.v24.i39.4436] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i39/4436.htm |
| Number | Citing Articles |
| 1 |
Yu Chen, Ruokun Li, Yuchen Yang, Di Ma, Jiahao Zhou, Chengyan Wang, Linghan Kong, Yongjun Chen, Fuhua Yan, Yuan Feng. Correlation analysis of structural and biomechanical properties of hepatocellular carcinoma tissue. Journal of Biomechanics 2022; 141 doi: 10.1016/j.jbiomech.2022.111227
|
| 2 |
Yelda Yüregir, Demet Kaçaroğlu, Seher Yaylacı. Cell Biology and Translational Medicine, Volume 21. Advances in Experimental Medicine and Biology 2023; 1450 doi: 10.1007/5584_2023_781
|
| 3 |
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Metabolism of N-nitrosodimethylamine, methylation of
macromolecules, and development of hepatic fibrosis in rodent models. Journal of Molecular Medicine 2020; 98(9) doi: 10.1007/s00109-020-01950-7
|
| 4 |
Ramakrishna Pai Jakribettu, Thomas George, Micheal L J Pais, Swathi Deepak Kulkarni, Srikant Natarajan, Manjeshwar Shrinath Baliga. Clinicohematological Details of Alcoholics Affected with Dengue: A Retrospective Observation. Journal of Clinical Infectious Disease Society 2024; 2(1) doi: 10.4103/CIDS.CIDS_10_24
|
| 5 |
Julie S. Di Martino, Tasmiah Akhter, Jose Javier Bravo-Cordero. Remodeling the ECM: Implications for Metastasis and Tumor Dormancy. Cancers 2021; 13(19) doi: 10.3390/cancers13194916
|
| 6 |
Inga Hochnadel, Lisa Hoenicke, Nataliia Petriv, Lavinia Neubert, Elena Reinhard, Tatjana Hirsch, Juan Carlos Lopez Alfonso, Huizhen Suo, Thomas Longerich, Robert Geffers, Ralf Lichtinghagen, Carlos Alberto Guzmán, Heiner Wedemeyer, Henrike Lenzen, Michael Peter Manns, Dunja Bruder, Tetyana Yevsa. Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers. Oncogene 2022; 41(14) doi: 10.1038/s41388-022-02222-z
|
| 7 |
Zhengyuan Xie, Yuanhao Wu, Sifu Liu, Yueliang Lai, Shenglan Tang. LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis. Clinics and Research in Hepatology and Gastroenterology 2021; 45(2) doi: 10.1016/j.clinre.2020.05.017
|
| 8 |
宇君 聂. Research Progress of CICs in Immunotherapy of Liver Cancer. Advances in Clinical Medicine 2024; 14(07) doi: 10.12677/acm.2024.1472004
|
| 9 |
Ananya Ajith, Jonathan Evraerts, Caroline Bouzin, Davide Brusa, Makram Merimi, Mehdi Najar, Françoise Smets, Etienne Sokal, Mustapha Najimi. Progression to fibrosis and hepatocellular carcinoma in DEN CCl4 liver mice, is associated with macrophage and striking regulatory T cells infiltration. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1601215
|
| 10 |
Canxia Shi, Sanne de Wit, Emina Učambarlić, George Markousis-Mavrogenis, Elles Screever, Wouter Meijers, Rudolf de Boer, Joseph Aboumsallem. Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms. Cancers 2023; 15(3) doi: 10.3390/cancers15030729
|
| 11 |
Sijia Wang, Wei Wang, Jia Zeng. Role of CALCR expression in liver cancer: Implications for the immunotherapy response. Molecular Medicine Reports 2024; 31(2) doi: 10.3892/mmr.2024.13406
|
| 12 |
Franz Geisslinger, Angelika M. Vollmar, Karin Bartel. Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?. Pharmaceuticals 2020; 13(7) doi: 10.3390/ph13070143
|
| 13 |
Isabella C. Wiest, Stephen Gilbert, Jakob N. Kather. From research to reality: The role of artificial intelligence applications in HCC care. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000136
|
| 14 |
Jihyeon Yoon, Won-Il Choi, Won Hee Lee, Gwi Bin Lee, Byeong Wook Choi, Pyeongkeun Kim, Yerim Heo, Dong Gun Kim, Hyeon Ah Kim, Myung Ae Bae, Seong Soon Kim, Eun Young Lee, Chang-Myung Oh, Hyeok Jae Lee, Hyun Woo Kim, Wan Namkung, Hail Kim, Jin Hee Ahn. Synthesis and Biological Evaluation of Peripheral 5HT2B Antagonists for Liver Fibrosis. Journal of Medicinal Chemistry 2025; 68(6) doi: 10.1021/acs.jmedchem.4c03003
|
| 15 |
Jian-Min Yuan, Yue Wang, Renwei Wang, Hung N. Luu, Jennifer Adams-Haduch, Woon-Puay Koh, Yu-Tang Gao, Jaideep Behari, Michael T. Lotze. Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case–Control Studies. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(2) doi: 10.1158/1055-9965.EPI-20-1081
|
| 16 |
Pei-Chin Lin, Wan-Yi Hsu, Po-Yi Lee, Shih-Hsien Hsu, Shyh-Shin Chiou. Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612654
|
| 17 |
Shan Yu, Matthew Ericson, Andrea Fanjul, Derek M. Erion, Maria Paraskevopoulou, Erin N. Smith, Banumathi Cole, Ryan Feaver, Corine Holub, Narender Gavva, Shane R. Horman, Jie Huang. Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells. ACS Chemical Biology 2022; 17(4) doi: 10.1021/acschembio.2c00006
|
| 18 |
Bahare Shokouhian, Hamidreza Aboulkheyr Es, Babak Negahdari, Atena Tamimi, Maryam Shahdoust, Anastasia Shpichka, Peter Timashev, Moustapha Hassan, Massoud Vosough. Hepatogenesis and hepatocarcinogenesis: Alignment of the main signaling pathways. Journal of Cellular Physiology 2022; 237(11) doi: 10.1002/jcp.30862
|
| 19 |
Firdevs TOPAL, Ünal TAŞDEMİR, Zeynep Zehra GÜMÜŞ, Süleyman GÜNAY, Hakan ÇAMYAR, Sabiye AKBULUT, Elif SARITAŞ YÜKSEL, Sezgin VATANSEVER, Fatih Esat TOPAL. Efficacy of P2/MS and AFP in Early Prediction of Hepatocellular Carcinoma Recurrence. Konuralp Tıp Dergisi 2020; 12(2) doi: 10.18521/ktd.632438
|
| 20 |
Nan Wang, Tianle Cao, Fei Han, Yibin Xie, Xiaodong Zhong, Sen Ma, Alan Kwan, Zhaoyang Fan, Hui Han, Xiaoming Bi, Mazen Noureddin, Vibhas Deshpande, Anthony G. Christodoulou, Debiao Li. Free‐breathing multitasking multi‐echo MRI for whole‐liver water‐specific T1, proton density fat fraction, and quantification. Magnetic Resonance in Medicine 2022; 87(1) doi: 10.1002/mrm.28970
|
| 21 |
Chan-Yen Kuo, Valeria Chiu, Po-Chun Hsieh, Chun-Yen Huang, S. Joseph Huang, I-Shiang Tzeng, Fu-Ming Tsai, Mao-Liang Chen, Chien-Ting Liu, Yi-Ru Chen. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. Journal of Pharmacological Sciences 2020; 144(3) doi: 10.1016/j.jphs.2020.07.014
|
| 22 |
Seohui Jang, Jihun Song, Eun Seok Kang, Sangwook Cheon, Taeho Kwak, Yihyun Kim, Seokjin Kong, Jinhyeok Choi, Minjeong Kang, Jaewon Khil, Hye Jun Kim, Jeongin Lee, Hwamin Lee, Seogsong Jeong. Alcohol-driven phenotypic transition in MASLD and risk of liver-related events. JHEP Reports 2026; doi: 10.1016/j.jhepr.2026.101866
|
| 23 |
Yara O. Aghabi, Alia Yasin, James I. Kennedy, Scott P. Davies, Amber E. Butler, Zania Stamataki. Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.662134
|
| 24 |
Shuya Cao, Zheyu Zhou, Chaobo Chen, Wenwen Li, Jinsong Liu, Jiawei Xu, Chunlong Zhao, Yihang Yuan, Zhenggang Xu, Huaiyu Wu, Guwei Ji, Xiaoliang Xu, Ke Wang. Early identification of hepatocellular carcinoma patients at high-risk of recurrence using the ADV score: a multicenter retrospective study. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03523-1
|
| 25 |
Anna Fishbein, Bruce D. Hammock, Charles N. Serhan, Dipak Panigrahy. Carcinogenesis: Failure of resolution of inflammation?. Pharmacology & Therapeutics 2021; 218 doi: 10.1016/j.pharmthera.2020.107670
|
| 26 |
Katherine J.P. Schwenger, Yasaman Ghorbani, Kuorosh Rezaei, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard. Relationship between dietary intake components and hepatic fibrosis in those with obesity before and 1 year after bariatric surgery. Nutrition 2023; 114 doi: 10.1016/j.nut.2023.112095
|
| 27 |
Erin Bresnahan, Katherine E. Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio. Mouse Models of Oncoimmunology in Hepatocellular Carcinoma. Clinical Cancer Research 2020; 26(20) doi: 10.1158/1078-0432.CCR-19-2923
|
| 28 |
Daniel A. Patten, Alex L. Wilkinson, Joanne M. O'Rourke, Shishir Shetty. Prognostic Value and Potential Immunoregulatory Role of SCARF1 in Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.565950
|
| 29 |
Daniel A. Patten, Alex L. Wilkinson, Ayla O'Keeffe, Shishir Shetty. Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer. Seminars in Liver Disease 2022; 42(01) doi: 10.1055/s-0041-1733876
|
| 30 |
Archittapon Nokkeaw, Chaiyaboot Ariyachet. Advances in Circular RNAs. Advances in Experimental Medicine and Biology 2025; 1485 doi: 10.1007/978-981-96-9428-0_21
|
| 31 |
Ankita Singh, Sidharth Harindranath, Prabhsaran Kaur, Arun Vaidya, Akash Shukla. Hepatocellular Carcinoma in Non-cirrhotic Portal Fibrosis/Idiopathic Portal Hypertension: An Under-recognized Complication—A Case Report and Literature Review. Journal of Clinical and Experimental Hepatology 2026; 16(4) doi: 10.1016/j.jceh.2026.103539
|
| 32 |
Takashi Yamaguchi, Katsunori Yoshida, Miki Murata, Kanehiko Suwa, Koichi Tsuneyama, Koichi Matsuzaki, Makoto Naganuma. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 23(11) doi: 10.3390/ijms23116270
|
| 33 |
Clara Wekesa, Gregory D Kirk, Jim Aizire, Eve-Marie Benson, Alex Karabarinde, Rosalind Parkes-Ratanshi, Ponsiano Ocama. Prevalence and Factors Associated With Liver Fibrosis Among Adult HIV-Infected Patients Attending Urban and Rural Care Clinics in Uganda. Open Forum Infectious Diseases 2020; 7(11) doi: 10.1093/ofid/ofaa483
|
| 34 |
Ying Meng, Tong Zhao, Zhengyi Zhang, Dekui Zhang. The role of hepatic microenvironment in hepatic fibrosis development. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2132418
|
| 35 |
Zeli Yin, Yilin Song, Liming Wang. Single-cell RNA sequencing reveals the landscape of the cellular ecosystem of primary hepatocellular carcinoma. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03574-0
|
| 36 |
Esref Alperen Bayraktar, Mary Salvatore. The intersection of liver cirrhosis and pulmonary fibrosis. Journal of Translational Medicine 2025; 24(1) doi: 10.1186/s12967-025-07449-4
|
| 37 |
Yuxin Liang, Ruoyi Yang, Jin Shang, Deyuan Zhong, Qinyan Yang, Yuhao Su, Ying Shi, Xiaolun Huang. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE. Journal of Cancer Research and Clinical Oncology 2023; 149(18) doi: 10.1007/s00432-023-05413-7
|
| 38 |
Sarah B. White, Dilip Rajasekhar Maddirela. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3 doi: 10.1007/16833_2022_122
|
| 39 |
Wen-Qi Zhang, Jia-Xin Sun, Shu-Ting Lan, Xiao-Mei Sun, Yi-Jing Guo, Bi-Chao Wen, Jie Chen, Gang Liu. Regulation of Fuzheng Huayu capsule on inhibiting the fibrosis-associated hepatocellular carcinogenesis. Journal of Asian Natural Products Research 2024; 26(10) doi: 10.1080/10286020.2024.2355132
|
| 40 |
Yuxin Liang, Zilong Zhang, Deyuan Zhong, Chunyou Lai, Zonglin Dai, Haibo Zou, Tianhang Feng, Jin Shang, Ying Shi, Xiaolun Huang. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913731
|
| 41 |
Bichen Zhang, Kalina Lapenta, Qi Wang, Jin Hyun Nam, Dongjun Chung, Marie E. Robert, Michael H. Nathanson, Xiaoyong Yang. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. Journal of Biological Chemistry 2021; 297(1) doi: 10.1016/j.jbc.2021.100887
|
| 42 |
Madisyn Oxley, Heather Francis, Keisaku Sato. Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies. Seminars in Liver Disease 2023; 43(01) doi: 10.1055/a-2015-1359
|
| 43 |
Andrea Dalbeni, Leonardo Antonio Natola, Marta Garbin, Mirko Zoncapè, Filippo Cattazzo, Anna Mantovani, Antonio Vella, Stefania Canè, Jasmin Kassem, Michele Bevilacqua, Simone Conci, Tommaso Campagnaro, Andrea Ruzzenente, Alessandra Auriemma, Alessandro Drudi, Giovanna Zanoni, Alfredo Guglielmi, Michele Milella, David Sacerdoti. Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients. Cancers 2023; 15(9) doi: 10.3390/cancers15092406
|
| 44 |
Satender Pal Singh, Nitisha Mondia. Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden. Hepatology Communications 2022; 6(12) doi: 10.1002/hep4.2046
|
| 45 |
Muhammed Mehdi Üremiş, Yusuf Türköz, Nuray Üremiş. Investigation of apoptotic effects of Cucurbitacin D, I, and E mediated by Bax/Bcl‐xL, caspase‐3/9, and oxidative stress modulators in HepG2 cell line. Drug Development Research 2024; 85(2) doi: 10.1002/ddr.22174
|
| 46 |
Kuo Du, Ji Hye Jun, Rajesh K. Dutta, Anna Mae Diehl. Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000411
|
| 47 |
Maya W. Haaker, Jung-Chin Chang, Brian K. Chung, Tobias S. Pieper, Falko Noé, Tongtong Wang, Niels Geijsen, Martin Houweling, Christian Wolfrum, Arie B. Vaandrager, Espen Melum, Bart Spee, J. Bernd Helms. Cellular Crosstalk Promotes Hepatic Progenitor Cell Proliferation and Stellate Cell Activation in 3D Co-culture. Cellular and Molecular Gastroenterology and Hepatology 2025; 19(5) doi: 10.1016/j.jcmgh.2025.101472
|
| 48 |
N.R. Matkovska. CHANGES IN FIBROSIS UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADEMETHYANINIUM AND ARGININE GLUTAMATE. Клінічна та профілактична медицина 2020; (3) doi: 10.31612/2616-4868.3(13).2020.07
|
| 49 |
Rong Qiu, Soichiro Murata, Chao Cheng, Akihiro Mori, Yunzhong Nie, Satoshi Mikami, Shunsuke Hasegawa, Tomomi Tadokoro, Satoshi Okamoto, Hideki Taniguchi. A Novel Orthotopic Liver Cancer Model for Creating a Human-like Tumor Microenvironment. Cancers 2021; 13(16) doi: 10.3390/cancers13163997
|
| 50 |
Pritam Sadhukhan, M. Talha Ugurlu, Mohammad O. Hoque. Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes. Cancers 2020; 12(12) doi: 10.3390/cancers12123822
|
| 51 |
Jiaxu Liang, Javier Ampuero, Javier Castell, Qiong Zhang, Sijia Zhang, Yong Chen, Manuel Romero-Gómez. Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosis. Annals of Hepatology 2023; 28(2) doi: 10.1016/j.aohep.2022.100889
|
| 52 |
Joseph George, Mutsumi Tsuchishima, Mikihiro Tsutsumi. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death & Disease 2019; 10(1) doi: 10.1038/s41419-018-1272-8
|
| 53 |
Alissa M. Cutrone, Heidi Yeh, Korkut Uygun, O. Berk Usta. Preclinical Models of Metabolic Dysfunction–Associated Steatotic Liver Disease for Therapeutic Testing.
Annual Review of Biomedical Engineering
2026; 28(1) doi: 10.1146/annurev-bioeng-081325-053420
|
| 54 |
H. Thamarai Kannan, Ieshita Pan. Next-generation therapies for hepatocellular carcinoma: CAR-T cell and anticancer peptide synergy. International Journal of Biological Macromolecules 2026; 344 doi: 10.1016/j.ijbiomac.2026.150512
|
| 55 |
Isabel Theresa Schobert, Lynn Jeanette Savic, Julius Chapiro, Khaled Bousabarah, Evan Chen, Fabian Laage-Gaupp, Jonathan Tefera, Nariman Nezami, MingDe Lin, Jeffrey Pollak, Todd Schlachter. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. European Radiology 2020; 30(10) doi: 10.1007/s00330-020-06931-5
|
| 56 |
Zaid Haddadin, Trinity Pike, Jebin J. Moses, Lisa V. Poulikakos. Colorimetric metasurfaces shed light on fibrous biological tissue. Journal of Materials Chemistry C 2021; 9(35) doi: 10.1039/D1TC02030G
|
| 57 |
Ahmed Hashem, Abubakr Awad, Hend Shousha, Wafaa Alakel, Ahmed Salama, Tahany Awad, Mahasen Mabrouk. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study. Arab Journal of Gastroenterology 2021; 22(2) doi: 10.1016/j.ajg.2021.04.003
|
| 58 |
Karoliina Stefanius, Kelly Servage, Kim Orth. Exosomes in cancer development. Current Opinion in Genetics & Development 2021; 66 doi: 10.1016/j.gde.2020.12.018
|
| 59 |
Abhilasha Srivastava, Harshita Sharma, Simran Khanna, Tejasvini Sadhu Balasundaram, Shibasish Chowdhury, Rajdeep Chowdhury, Sudeshna Mukherjee. Interleukin-6 Induced Proliferation Is Attenuated by Transforming Growth Factor-β-Induced Signaling in Human Hepatocellular Carcinoma Cells. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.811941
|
| 60 |
Ifeoluwa Temitayo Oyeyemi, Abiola Mojisola Asowata-Ayodele, Ademola Oluwatobiloba Adetula, Kabirat Adedunmola Sulaiman, Demilade Elizabeth Omape, Muyiwa Samuel Fageyinbo. Inhibitory effect of the methanol extract of Clerodendrum volubile Linn. on carbon tetrachloride-induced early hepatic fibrogenesis: in silico and in vivo study. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-39090-6
|
| 61 |
Chen Yang, Hailin Zhang, Mengnuo Chen, Siying Wang, Ruolan Qian, Linmeng Zhang, Xiaowen Huang, Jun Wang, Zhicheng Liu, Wenxin Qin, Cun Wang, Hualian Hang, Hui Wang. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. eLife 2022; 11 doi: 10.7554/eLife.71880
|
| 62 |
Alexander Kusnik, Andreas Teufel. Einfluss von ASS auf das Hepatozelluläre Karzinom und die Leber-bedingte Mortalität. Zeitschrift für Gastroenterologie 2020; 58(10) doi: 10.1055/a-1162-1200
|
| 63 |
Matthew Brovold, Dale Keller, Shay Soker. Differential fibrotic phenotypes of hepatic stellate cells within 3D liver organoids. Biotechnology and Bioengineering 2020; 117(8) doi: 10.1002/bit.27379
|
| 64 |
Rachel M. Lee, Adriana C. Gamboa, Michael K. Turgeon, Adam Yopp, Emily L. Ryon, Joshua P. Kronenfeld, Neha Goel, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Shishir K. Maithel, Maria C. Russell. The Evolving Landscape of Hepatocellular Carcinoma. The American Surgeon™ 2020; 86(7) doi: 10.1177/0003134820939934
|
| 65 |
LINGLI ZHANG, YAN LI, JINGXIN MAO. Research progress on natural products against hepatocellular carcinoma. BIOCELL 2024; 48(6) doi: 10.32604/biocell.2024.050396
|
| 66 |
Yun Hua Lee, David Tai, Connie Yip, Su Pin Choo, Valerie Chew. Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.568759
|
| 67 |
Stacey M. Stein. Emerging Role of Immune Therapy in HCC. Digestive Disease Interventions 2021; 5(03) doi: 10.1055/s-0041-1722932
|
| 68 |
Zhiping Hu, Takeshi Kurihara, Yiyue Sun, Zeliha Cetin, Rodrigo M. Florentino, Lanuza A. P. Faccioli, Zhenghao Liu, Bo Yang, Alina Ostrowska, Joseph D. Locker, Alejandro Soto-Gutierrez, Evan R. Delgado. A rat model of cirrhosis with well-differentiated hepatocellular carcinoma induced by thioacetamide. Frontiers in Gastroenterology 2024; 3 doi: 10.3389/fgstr.2024.1427820
|
| 69 |
Subhas Das, Soumyabrata Chatterjee, Tushar Patel, Soma Banerjee. RNA renaissance: Harnessing non-coding RNA therapeutics for hepatocellular carcinoma. Pharmacology & Therapeutics 2026; 277 doi: 10.1016/j.pharmthera.2025.108956
|
| 70 |
Samantha V. Llewellyn, Marije Niemeijer, Penny Nymark, Martijn J. Moné, Bob van de Water, Gillian E. Conway, Gareth J. S. Jenkins, Shareen H. Doak. In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment. Small 2021; 17(15) doi: 10.1002/smll.202006055
|
| 71 |
Xian Zhong, Haiyi Long, Lili Chen, Yuhua Xie, Yifan Shi, Jianyun Peng, Ruiying Zheng, Liya Su, Yu Duan, Xiaoyan Xie, Manxia Lin. Stiffness on shear wave elastography as a potential microenvironment biomarker for predicting tumor recurrence in HBV-related hepatocellular carcinoma. Insights into Imaging 2023; 14(1) doi: 10.1186/s13244-023-01505-7
|
| 72 |
Alec T. McIntosh, Renhuizi Wei, Jaeil Ahn, Brad E. Aouizerat, Seble G. Kassaye, Michael H. Augenbraun, Jennifer C. Price, Audrey L. French, Stephen J. Gange, Kathryn M. Anastos, Radoslav Goldman, Jason T. Blackard. A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women. PLOS ONE 2021; 16(3) doi: 10.1371/journal.pone.0247277
|
| 73 |
Raffaella Maria Gadaleta, Antonio Moschetta. Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver. Journal of Hepatology 2021; 75(6) doi: 10.1016/j.jhep.2021.07.029
|
| 74 |
Szu‐Yuan Wu, Wan‐Yu Yang, Chun‐Chia Cheng, Kuan‐Hao Lin, Bonifasius Putera Sampurna, Suat‐Ming Chan, Chiou‐Hwa Yuh. Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling. Clinical and Translational Medicine 2020; 10(8) doi: 10.1002/ctm2.252
|
| 75 |
Maximilian Schinagl, Tamara Tomin, Juergen Gindlhuber, Sophie Honeder, Raphael Pfleger, Matthias Schittmayer, Michael Trauner, Ruth Birner-Gruenberger. Proteomic Changes of Activated Hepatic Stellate Cells. International Journal of Molecular Sciences 2021; 22(23) doi: 10.3390/ijms222312782
|
| 76 |
Xiaodong Wang, Chunyue Wang, Huimin Tian, Bolin Wu, Wen Cheng. Tumor Microenvironment‐Related Sonodynamic Therapy Mediates Tumor Therapy. Advanced Therapeutics 2023; 6(12) doi: 10.1002/adtp.202300265
|
| 77 |
Bridget P. Keenan, Lawrence Fong, Robin K. Kelley. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0749-z
|
| 78 |
Zeli Yin, Chengyong Dong, Keqiu Jiang, Zhe Xu, Rui Li, Kun Guo, Shujuan Shao, Liming Wang. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0782-x
|
| 79 |
Siddhant Tripathi, Yashika Sharma, Dileep Kumar. Biological Cargo: Exosomes and their Role in Cancer Progression and Metastasis. Current Topics in Medicinal Chemistry 2025; 25(3) doi: 10.2174/0115680266304636240626055711
|
| 80 |
Motofumi Kumazoe, Emi Miyamoto, Chihiro Oka, Miyuki Kondo, Ren Yoshitomi, Hiroaki Onda, Yu Shimada, Yoshinori Fujimura, Hirofumi Tachibana. miR-12135 ameliorates liver fibrosis accompanied with the downregulation of integrin subunit alpha 11. iScience 2024; 27(1) doi: 10.1016/j.isci.2023.108730
|
| 81 |
Debanjan Dhar, Jacopo Baglieri, Tatiana Kisseleva, David A Brenner. Mechanisms of liver fibrosis and its role in liver cancer. Experimental Biology and Medicine 2020; 245(2) doi: 10.1177/1535370219898141
|
| 82 |
Megan E. Bannister, Devnandan A. Chatterjee, Shishir Shetty, Daniel A. Patten. The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential. International Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252313167
|
| 83 |
Sammy Saab, Nguyen Pham, William Wu, Long Dang, An Dang, Jung Yum, Kisub Shim, Steven Wu. Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naïve Chronic Hepatitis B Patients. Digestive Diseases and Sciences 2022; 67(11) doi: 10.1007/s10620-022-07402-1
|
| 84 |
Vincent Chiu, Christine Yee, Nathan Main, Igor Stevanovski, Matthew Watt, Trevor Wilson, Peter Angus, Tara Roberts, Nicholas Shackel, Chandana Herath. Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model. Clinical Science 2024; 138(19) doi: 10.1042/CS20240560
|
| 85 |
Biao Li, Yuchen Ma, Lina Tan, Huan Ren, Lifang Wu, Qian Su, Jue Song, Wei Chen, Peng Gong, Yong Jin. 20-Hydroxytetraenoic acid induces hepatic fibrosis via the TGF-β1/Smad3 signaling pathway. Toxicology Letters 2023; 373 doi: 10.1016/j.toxlet.2022.11.001
|
| 86 |
Ke Xu, Tao Gu, Ke Su, Xin Liu, Bingsheng He, Jie He, Hao Chi, Xuancheng Zhou, Hanlin Liu, Rui Xiao, Xue Tang, Qinni Ye, Xue Zhou, Yingpeng Liu, Jie Xiong, Pan Wang, Han Li, Kun He, Lu Guo, Yunwei Han. Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02914-4
|
| 87 |
Mon-Yuan Yang, Tung-Wei Hung, Chau-Jong Wang, Tsui-Hwa Tseng. Inhibitory Effect of Nelumbo nucifera Leaf Extract on 2-Acetylaminofluorene-induced Hepatocarcinogenesis Through Enhancing Antioxidative Potential and Alleviating Inflammation in Rats. Antioxidants 2019; 8(9) doi: 10.3390/antiox8090329
|
| 88 |
Ha Thi Nga, Ji Sun Moon, Jingwen Tian, Ho Yeop Lee, Seok-Hwan Kim, Young-Sun Lee, Jae-Han Jeon, Hyon-Seung Yi. Interleukin-10 Attenuates Liver Fibrosis Exacerbated by Thermoneutrality. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.672658
|
| 89 |
Jacopo Baglieri, Cuili Zhang, Shuang Liang, Xiao Liu, Takahiro Nishio, Sara B. Rosenthal, Debanjan Dhar, Hua Su, Min Cong, Jidong Jia, Mojgan Hosseini, Michael Karin, Tatiana Kisseleva, David A. Brenner. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice. The American Journal of Pathology 2021; 191(9) doi: 10.1016/j.ajpath.2021.05.019
|
| 90 |
Samantha Ligi, Arm Ali, Guangdong Yang. Cystathionine gamma-lyase deficiency exaggerates diethylnitrosamine-induced liver damage in mice. Nitric Oxide 2024; 151 doi: 10.1016/j.niox.2024.08.001
|
| 91 |
Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter-Dick. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms22189799
|
| 92 |
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(7) doi: 10.3390/ijms20071745
|
| 93 |
J. Cárdenas-Escudero, C. Mármol-Rojas, S. Escribano Pintor, D. Galán-Madruga, J. O. Cáceres. Honey polyphenols: regulators of human microbiota and health. Food & Function 2023; 14(2) doi: 10.1039/D2FO02715A
|
| 94 |
Manal A. M. Mahmoud, Abd El-Aziz A. Said, Hanan H. Abd-Elhafeez, Soha A. Soliman, Usama T. Mahmoud. Maize stover burning exposure accountable for remarkable environmental and health risk in broiler chickens. BMC Veterinary Research 2025; 21(1) doi: 10.1186/s12917-025-04476-7
|
| 95 |
Homa Fatma, Mohd Jameel, Hifzur R. Siddique. An Update on Phytochemicals in Redox Homeostasis: “Virtuous or Evil” in Cancer Chemoprevention?. Chemistry 2023; 5(1) doi: 10.3390/chemistry5010017
|
| 96 |
Razvan Cerban, Speranta Iacob, Carmen Ester, Mihaela Ghioca, Mirela Chitul, Razvan Iacob, Liana Gheorghe. Liver Elastography Methods for Diagnosis of De Novo and Recurrent Hepatocellular Carcinoma. Diagnostics 2025; 15(9) doi: 10.3390/diagnostics15091087
|
| 97 |
Yuhao Su, Yuxin Liang, Deyuan Zhong, Hongtao Yan, Qinyan Yang, Jin Shang, Yahui Chen, Xiaolun Huang. Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13867-w
|
| 98 |
Abdullah Ely, Kristie Bloom, Mohube Betty Maepa, Patrick Arbuthnot. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S268291
|
| 99 |
Xiaomin Duan, Longyang Xiao, Haichen Zhao, Yuanxiang Gao, Lili Wang, Haiyang Yu, Xiaoyuan Zhou, Xiaojuan Shi, Zhiming Li. Hypoxia Imaging in Hepatic Fibrosis: A Preliminary Application of CAIX‐Targeted MRI Probe in Rats. NMR in Biomedicine 2026; 39(4) doi: 10.1002/nbm.70249
|
| 100 |
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 2021; 7(7) doi: 10.1016/j.trecan.2021.01.012
|
| 101 |
Yinghui Zhu, Dezhi Shan, Lianyi Guo, Shujia Chen, Xiaofei Li. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma. International Journal of General Medicine 2022; doi: 10.2147/IJGM.S343350
|
| 102 |
Anqi Lin, Minying Xiong, Bufu Tang, Aimin Jiang, Junyi Shen, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo. Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities. Hepatology International 2025; 19(4) doi: 10.1007/s12072-025-10838-y
|
| 103 |
Jiongyi Yan, Xuewan Fang, Yinyi Feng, Xiaojuan Cui, Fang Li, Weisheng Luo, Xiaocong Ma, Jianqin Liang, Jianfang Feng. Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database. Annals of Hepatology 2022; 27(3) doi: 10.1016/j.aohep.2022.100681
|
| 104 |
Alex L. Wilkinson, Maria Qurashi, Shishir Shetty. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00990
|
| 105 |
Hua Wang, Shaoping Zheng, Hongbo Jiang, Xuejia Wang, Fengqin Zhou, Zhihong Weng. Single-cell transcriptomic analysis reveals a novel cell state and switching genes during hepatic stellate cell activation in vitro. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03263-4
|
| 106 |
Kazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, Kazuya Kariyama, Hidenori Toyoda, Michihiro Iwaki, Hideki Hayashi, Satoshi Oeda, Hideyuki Hyogo, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Tsubasa Tsutsumi, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takashi Kumada, Takeshi Okanoue. Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease. Hepatology Research 2024; 54(10) doi: 10.1111/hepr.14039
|
| 107 |
Yuxin Liang, Zirui Wang, Yujiao Peng, Zonglin Dai, Chunyou Lai, Yuqin Qiu, Yutong Yao, Ying Shi, Jin Shang, Xiaolun Huang. Development of ensemble learning models for prognosis of hepatocellular carcinoma patients underwent postoperative adjuvant transarterial chemoembolization. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1169102
|
| 108 |
Anindita Banerjee, Patrizia Farci. Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression. International Journal of Molecular Sciences 2024; 25(16) doi: 10.3390/ijms25168641
|
| 109 |
Elham A. Abd-Allah, Ahlam A. Alahmadi, Hanan S.A. Waly, Bassam A. Alahmadi. Anti-inflammatory Properties of Curcumin May Be Useful for Treating the Deleterious Effects of CCL4 on Liver and Spleen. Asian Journal of Animal and Veterinary Advances 2019; 15(1) doi: 10.3923/ajava.2020.1.12
|
| 110 |
Bart Vanderborght, Kevin De Muynck, Sander Lefere, Anja Geerts, Helena Degroote, Xavier Verhelst, Hans Van Vlierberghe, Lindsey Devisscher. Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model. Oncotarget 2020; 11(48) doi: 10.18632/oncotarget.27830
|
| 111 |
Marta Maestri, Maria Pallozzi, Francesco Santopaolo, Lucia Cerrito, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Durvalumab: an investigational agent for unresectable hepatocellular carcinoma. Expert Opinion on Investigational Drugs 2022; 31(4) doi: 10.1080/13543784.2022.2033208
|
| 112 |
Tian-Cheng Wang, Tian-Zhi An, Jun-Xiang Li, Peng-Fei Pang. Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE. Risk Management and Healthcare Policy 2021; doi: 10.2147/RMHP.S316740
|
| 113 |
Bianca Florentina Pîrvu, Diana Clenciu , Luiza Andreea Beldie , Cristina Camelia Dica , Marilena Alexandra Burticală , Tiberiu Ştefăniţă Ţenea-Cojan , Adina Mitrea , Anca Maria Amzolini , Ion Cristian Efrem . The burden of cancer in metabolic dysfunction-associated steatotic liver disease. Romanian Journal of Morphology and Embryology 2025; 65(4) doi: 10.47162/RJME.65.4.09
|
| 114 |
Ruheng Hua, Pengfei Yu, Wanting Zheng, Nuwa Wu, Wangjianfei Yu, Qingyu Kong, Jun He, Lei Qin. Tim-1-mediated extracellular matrix promotes the development of hepatocellular carcinoma. Acta Biochimica et Biophysica Sinica 2024; 56(12) doi: 10.3724/abbs.2024191
|
| 115 |
Andrew C. Picel, Daniel Y. Sze. Image-Guided Interventions in Oncology. 2020; doi: 10.1007/978-3-030-48767-6_2
|
| 116 |
Kosar Nouri, Abbas Piryaei, Homeyra Seydi, Ibrahim Zarkesh, Ibrahim Ghoytasi, Bahare Shokouhian, Mustapha Najimi, Massoud Vosough. Fibrotic liver extracellular matrix induces cancerous phenotype in biomimetic micro-tissues of hepatocellular carcinoma model. Hepatobiliary & Pancreatic Diseases International 2025; 24(1) doi: 10.1016/j.hbpd.2024.09.003
|
| 117 |
Chrystelle L Vilfranc, Li-Xiao Che, Krushna C Patra, Liang Niu, Olugbenga Olowokure, Jiang Wang, Shimul A Shah, Chun-Ying Du. BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis. World Journal of Hepatology 2021; 13(3): 343-361 doi: 10.4254/wjh.v13.i3.343
|
| 118 |
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
|
| 119 |
Alessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, Stefano Gitto, Fabio Marra. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells 2021; 10(10) doi: 10.3390/cells10102759
|
| 120 |
Maria Kopsida, Ada Lerma Clavero, Jaafar Khaled, David Balgoma, Clara Luna-Marco, Azazul Chowdhury, Sofi Sennefelt Nyman, Fredrik Rorsman, Charlotte Ebeling Barbier, Peter Bergsten, Hans Lennernäs, Mikael Hedeland, Femke Heindryckx. Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells. Molecular Metabolism 2024; 79 doi: 10.1016/j.molmet.2023.101846
|
| 121 |
Daniel Neureiter, Tobias Kiesslich, Matthias Ocker. Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma. Medical Sciences 2026; 14(1) doi: 10.3390/medsci14010110
|
| 122 |
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03080-9
|
| 123 |
Chonnikarn Jirasit, Panida Navasumrit, Krittinee Chaisatra, Chalida Chompoobut, Somchamai Waraprasit, Varabhorn Parnlob, Mathuros Ruchirawat. Genotoxicity and fibrosis in human hepatocytes in vitro from exposure to low doses of PBDE-47, arsenic, or both chemicals. Chemico-Biological Interactions 2025; 410 doi: 10.1016/j.cbi.2025.111410
|
| 124 |
Nuray Üremiş, Muhammed Mehdi Üremiş. The Role of Natural Products in Liver Cancer: Focus on Angiogenesis, Inflammation, Oxidative Stress, and Apoptosis. Molecular Nutrition & Food Research 2026; 70(1) doi: 10.1002/mnfr.70332
|
| 125 |
Veena Gopinath, Mullam Kunnathu A. Shamsitha, Vaishak Penarveettil Nair, Punnakkal Seena, Rao M. Uppu, Achuthan C. Raghavamenon. Thermally Oxidized Coconut Oil as Fat Source in High-Fat Diet Induces Hepatic Fibrosis in Diabetic Rat Model. Cell Biochemistry and Biophysics 2021; 79(3) doi: 10.1007/s12013-021-01009-5
|
| 126 |
Da-Young Lee, Sun-Mi Yun, Moon-Young Song, Sang-Deok Ji, Jong-Gon Son, Eun-Hee Kim. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats. Cells 2020; 9(3) doi: 10.3390/cells9030568
|
| 127 |
Clara Wekesa, Ponsiano Ocama, Rosalind Parkes-Ratanshi, Gregory D. Kirk. Burden and correlates of significant liver fibrosis among HIV-infected and uninfected adults in urban Uganda. Dialogues in Health 2022; 1 doi: 10.1016/j.dialog.2022.100027
|
| 128 |
Aamir Salam Teeli, Kamila Łuczyńska, Effi Haque, Mohmmad Abrar Gayas, Dawid Winiarczyk, Hiroaki Taniguchi. Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver. Cancers 2021; 13(21) doi: 10.3390/cancers13215357
|
| 129 |
Alex L. Wilkinson, Samuel Hulme, James I. Kennedy, Emily R. Mann, Paul Horn, Emma L. Shepherd, Kelvin Yin, Marco Y.W. Zaki, Gareth Hardisty, Wei-Yu Lu, Pia Rantakari, David H. Adams, Marko Salmi, Matthew Hoare, Daniel A. Patten, Shishir Shetty. The senescent secretome drives PLVAP expression in cultured human hepatic endothelial cells to promote monocyte transmigration. iScience 2023; 26(10) doi: 10.1016/j.isci.2023.107966
|
| 130 |
Xianbin Xu, Danfeng Lin, Sheng Tu, Shiqi Gao, Anwen Shao, Jifang Sheng. Is Ferroptosis a Future Direction in Exploring Cryptococcal Meningitis?. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.598601
|
| 131 |
Shanu Jain, Kenneth A. Jacobson. Purinergic Signaling in Liver Pathophysiology. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.718429
|